My research investigates synthetic compounds for their therapeutic potential and impact on tumor progression especially gliomas, with prior work exploring neurocognitive decline in endocrine disease by linking molecular mechanisms to clinical outcomes. I am passionate about interdisciplinary approaches to advance cancer research and improve patient care. Open to collaborations in oncology, molecular biology, and drug development, I aim to connect and share insights to drive innovation in these critical areas.